Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Wassmann

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a reviewAlexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
Respiration; International Review of Thoracic Diseases|May 19, 2026
Development of a physician-independent screening for rheumatoid arthritis-associated interstitial lung disease - a case-control and cohort studyRobin Tiede, Frank Reichenberger, Carina Fischinger, et al.
The American Journal of Cardiology|November 9, 2005
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery diseasePim van der Harst, Lodewijk J Wagenaar, Hendrik Buikema, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyJuan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on StrokePatrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisPaul M Haller, Niema Kazem, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 6, 2021
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyMaria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a reviewAlexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
Respiration; International Review of Thoracic Diseases|May 19, 2026
Development of a physician-independent screening for rheumatoid arthritis-associated interstitial lung disease - a case-control and cohort studyRobin Tiede, Frank Reichenberger, Carina Fischinger, et al.
The American Journal of Cardiology|November 9, 2005
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery diseasePim van der Harst, Lodewijk J Wagenaar, Hendrik Buikema, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyJuan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on StrokePatrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisPaul M Haller, Niema Kazem, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 6, 2021
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyMaria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
Pageof 8